RAGGI, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 2.049
EU - Europa 1.424
AS - Asia 401
AF - Africa 6
SA - Sud America 1
Totale 3.881
Nazione #
US - Stati Uniti d'America 2.047
RU - Federazione Russa 721
IT - Italia 202
IE - Irlanda 153
PL - Polonia 142
SG - Singapore 137
SE - Svezia 127
HK - Hong Kong 116
CN - Cina 58
IN - India 28
JO - Giordania 21
KR - Corea 19
GB - Regno Unito 18
FI - Finlandia 16
VN - Vietnam 11
DE - Germania 10
MK - Macedonia 8
CI - Costa d'Avorio 6
UA - Ucraina 6
NL - Olanda 5
CH - Svizzera 4
FR - Francia 3
PH - Filippine 3
TW - Taiwan 3
AL - Albania 2
AT - Austria 2
CA - Canada 2
LB - Libano 2
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BR - Brasile 1
EE - Estonia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
RO - Romania 1
RS - Serbia 1
TR - Turchia 1
Totale 3.881
Città #
Santa Clara 1.021
Dublin 153
Warsaw 142
Singapore 122
Fairfield 116
Ashburn 88
Chandler 86
Hong Kong 80
Altamura 62
Lawrence 62
Florence 57
Houston 50
Moscow 44
Seattle 44
Cambridge 39
Wilmington 38
Woodbridge 37
Princeton 32
Boston 29
Kent 21
Mumbai 21
Seoul 19
Shanghai 19
Ann Arbor 17
San Diego 17
West Jordan 16
Beijing 15
Milan 14
Buffalo 13
Helsinki 13
Dong Ket 10
Medford 8
Abidjan 6
Boardman 5
New York 5
Pune 5
Bern 4
Biella 4
Cisano Bergamasco 4
Hillsboro 4
London 4
Los Angeles 4
Andover 3
Falls Church 3
Ohrid 3
Redwood City 3
Rome 3
Amsterdam 2
Castelliri 2
Lappeenranta 2
Munich 2
Naples 2
Norwalk 2
Phoenix 2
Rennes 2
Rho 2
Scandicci 2
Sesto Fiorentino 2
Silea 2
Toronto 2
Wuhan 2
Yubileyny 2
Almaty 1
Arezzo 1
Belgrade 1
Berlin 1
Brentford 1
Brussels 1
Cagayan de Oro 1
Catania 1
Colombo 1
Falkenstein 1
Guangzhou 1
Hangzhou 1
Hounslow 1
Istanbul 1
Lanzhou 1
Laurel 1
Makati City 1
New Bedfont 1
Ponte Buggianese 1
Portland 1
Putian 1
Redmond 1
Romola 1
San Mateo 1
Sao Goncalo 1
Sarajevo 1
Segrate 1
Senago 1
Skopje 1
St Petersburg 1
Tallinn 1
Timisoara 1
Viterbo 1
Wuhu 1
Yekaterinburg 1
Totale 2.630
Nome #
The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cells 169
The role of stroma in cholangiocarcinoma: The intriguing interplay between fibroblastic component, immune cell subsets and tumor epithelium 147
Role of myeloid-epithelial-reproductive tyrosine kinase and macrophage polarization in the progression of atherosclerotic lesions associated with nonalcoholic fatty liver disease 136
Aberrant Glycosphingolipid Pattern in Human Cholangiocarcinoma Stem-Like Subsets 132
Ganglioside composition correlates with the malignant phenotype of cholangiocarcinoma cells and modulates cell adhesion 131
CXCR7 contributes to the aggressive phenotype of cholangiocarcinoma cells 128
Multifaceted Aspects of Metabolic Plasticity in Human Cholangiocarcinoma: An Overview of Current Perspectives 126
Fatty acids regulate the biology of cholangiocarcinoma cells 123
Antitumor Activity of a Novel Fibroblast Growth Factor Receptor Inhibitor for Intrahepatic Cholangiocarcinoma 119
Extracellular signal-regulated kinase 5 regulates the malignant phenotype of cholangiocarcinoma cells 114
Role of chemokines in the biology of cholangiocarcinoma 108
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies. 107
Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma 105
Macrophage MerTK promotes profibrogenic cross-talk with hepatic stellate cells via soluble mediators 100
Cholangiocarcinoma 2020: the next horizon in mechanisms and management 89
The profile on intracellular gangliosides correlates with the malignant phenotype of cholangiocarcinoma cells and modulates cells adhesion 85
A novel multidrug‐resistant cell line from an italian intrahepatic cholangiocarcinoma patient 82
The protease-inhibitor SerpinB3 as a critical modulator of the stem-like subset in human cholangiocarcinoma 80
The role of the hedgehog pathway in cholangiocarcinoma 75
Dysregulation of Iron Metabolism in Cholangiocarcinoma Stem-like Cells 73
Establishment and characterization of a new intrahepatic cholangiocarcinoma cell line resistant to gemcitabine 69
Assessment of a high sensitivity method for identification of IDH1 R132x mutations in tumors and plasma of Intrahepatic Cholangiocarcinoma patients 69
DNA Damage Response Inhibitors in Cholangiocarcinoma: Current Progress and Perspectives 68
Cell death and impairment of glucose-stimulated insulin secretion induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the β-cell line INS-1E 68
Paclitaxel Restores Sensitivity to Chemotherapy in Preclinical Models of Multidrug-Resistant Intrahepatic Cholangiocarcinoma 67
Plasma membrane γ-glutamyltransferase activity facilitates the uptake of vitamin C in melanoma cells 60
Establishment and characterization of a new spontaneously immortalized ER-/PR-/HER2+ human breast cancer cell line, DHSF-BR16 59
Combined Inhibition of Smoothened and the DNA Damage Checkpoint WEE1 Exerts Antitumor Activity in Cholangiocarcinoma 57
Free episomal and integrated HBV DNA in HBsAg-negative patients with intrahepatic cholangiocarcinoma 57
Modeling pathogenesis of primary liver cancer in lineage-specific mouse cell types 57
Experimental models to unravel the molecular pathogenesis, cell of origin and stem cell properties of cholangiocarcinoma 55
Glutathione transferase omega 1-1 (GSTO1-1) plays an anti-apoptotic role in cell resistance to cisplatin toxicity 53
Genomic perturbations reveal distinct regulatory networks in intrahepatic cholangiocarcinoma 52
Methylation and liver cancer 51
Definition of ubiquitination modulator COP1 as a novel therapeutic target in human hepatocellular carcinoma. 49
Iron metabolism in liver cancer stem cells 49
Epigenetic reprogramming modulates malignant properties of human liver cancer 48
Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance 47
Metabolic reprogramming in cholangiocarcinoma 45
Cholangiocarcinoma stem-like subset shapes tumor-initiating niche by educating associated macrophages 43
Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) 42
Antitumor effects in hepatocarcinoma of isoform-selective inhibition of HDAC2 41
Stem-like plasticity and heterogeneity of circulating tumor cells: current status and prospect challenges in liver cancer 41
An integrated genomic and epigenomic approach predicts therapeutic response to zebularine in human liver cancer. 41
Mesenchymal stem cells, aging and regenerative medicine. 41
Impact of microenvironment and stem-like plasticity in cholangiocarcinoma: molecular networks and biological concepts 41
Hepatocyte growth factor/c-met signaling is required for stem-cell-mediated liver regeneration in mice. 40
Cell death and impairment of glucose-stimulated insulin secretion induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the beta-cell line INS-1E. 40
Plasma membrane gamma-glutamyltransferase activity facilitates the uptake of vitamin C in melanoma cells 39
Human hepatic cancer stem cells are characterized by common stemness traits and diverse oncogenic pathways. 39
Nuclear translocation of glutathione transferase omega is a progression marker in Barrett's esophagus. 38
Telomere dysfunction in peripheral blood mononuclear cells from patients with primary biliary cirrhosis 38
More than shots in the dark: improving patient stratification to move closer to personalised therapies in intrahepatic cholangiocarcinoma 37
RNA-seq reveals distinctive RNA profiles of small extracellular vesicles from different human liver cancer cell lines 35
3D Modeling: Insights into the Metabolic Reprogramming of Cholangiocarcinoma Cells 31
Altered fatty acid metabolism rewires cholangiocarcinoma stemness features 25
Totale 3.961
Categoria #
all - tutte 13.712
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.712


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020182 0 0 0 0 0 28 27 28 30 26 26 17
2020/2021316 27 32 27 32 23 23 20 17 35 36 21 23
2021/2022258 27 2 3 8 4 15 1 17 63 15 28 75
2022/2023613 62 166 51 16 14 105 84 37 52 4 12 10
2023/2024422 11 30 41 30 31 40 19 101 16 35 60 8
2024/20252.090 69 277 145 430 878 291 0 0 0 0 0 0
Totale 3.961